ASH Advocates for Diversity in Medicine

The Society is disappointed in the recently issued SCOTUS Decision in SFFA vs Harvard/UNC and emphasizes the importance of fostering a diverse health care workforce.

(WASHINGTON, June 29, 2023) – The American Society of Hematology (ASH), a member of the Council of Medical Specialty Societies (CMSS), supports the CMSS statement expressing disappointment in the recent ruling by the United States Supreme Court that restricts the consideration of an applicant’s racial or ethnic background in higher education admissions.

The court’s decisions in Students for Fair Administration (SFFA) vs Harvard and SFFA vs the University of North Carolina could be detrimental to crucial efforts to support diversity in hematology, medicine, and the entire health care profession.

Read CMSS’s official statement.

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH’s flagship journal, Blood (www.bloodjournal.org), is the most cited peer-reviewed publication in the field, and Blood Advances (www.bloodadvances.org) is an open-access, online journal that publishes more peer-reviewed hematology research than any other academic journal worldwide.

Contact:
Kira Sampson, American Society of Hematology
ksampson@hematology.org; 202-499-1796